Bayesian Capital Management’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,404
Closed -$292K 874
2024
Q3
$292K Buy
+1,404
New +$282K 0.03% 485
2022
Q4
Sell
-3,242
Closed -$443K 942
2022
Q3
$443K Buy
+3,242
New +$503K 0.09% 312
2021
Q3
Sell
-1,186
Closed -$205K 484
2021
Q2
$205K Sell
1,186
-94
-7% -$17K 0.05% 363
2021
Q1
$230K Buy
+1,280
New +$236K 0.05% 420
2018
Q3
Sell
-3,874
Closed -$857K 739
2018
Q2
$857K Buy
3,874
+2,231
+136% +$412K 0.19% 133
2018
Q1
$288K Buy
+1,643
New +$266K 0.07% 405

Other funds holding MSGS

Bayesian Capital Management's MSGS Position: Q4 2024 in Review

Bayesian Capital Management sold out of Madison Square Garden (MSGS) in Q4 2024, closing a stake of 1,404 shares — an estimated $292K sold.

Bayesian Capital Management first reported a position in MSGS in Q1 2018 and held it in 6 quarters. The position peaked at $857K in Q2 2018. 343 funds tracked by Wall St. Rank hold MSGS as of Q4 2024.

  • Bayesian Capital Management reported no remaining Madison Square Garden position as of Q4 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 1,404 Madison Square Garden shares in Q4 2024, an estimated $292K.
  • Bayesian Capital Management first reported a position in Madison Square Garden in Q1 2018 and held it in 6 quarters.
  • Bayesian Capital Management's Madison Square Garden position peaked at $857K in Q2 2018.
  • 343 funds tracked by Wall St. Rank held Madison Square Garden as of Q4 2024.

Based on Bayesian Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.